All China Stocks -All Information About China Stocks Traded In U.S. Stock Markets

AllChinaStocks

China Biologic Products, Inc. (CBPO), 2017-05-26 4:36:35 PM

 

114.28 +0.16 (+0.14%)

5/26/2017  4:00pm

Open:

114.65

Pre close:

114.12

High:

114.96

Low:

111.42

Volume:

74,186

Market Cap:

3.11B

Overall  

    ****   

What's this
Target Six months: 140.70     One year: 164.33
Support Support1: 112.20    Support2: 107.10
Resistance Resistance1: 120.46    Resistance2: 140.70 
Pivot 113.00 
Moving Averages

MA(5): 113.58     MA(20): 114.26

MA(100): 108.91     MA(250): 113.38

MACD MACD(12,26): 0.44     Signal(12,26,9): 0.69
Stochastic Oscillator %K(14,3): 62.59     %D(3): 54.84
RSI RSI(14): 54.92

Financials: 

EPS

3.860

EPS Est. Current Year

5.090

EPS Est. Next Quarter

1.320

EPS Est. Next Year

5.920

Forward EPS

Book Value (p.s.)

18.480

PEG Ratio

1.60

Profit Margin

30.71

Operating Margin

42.18

Return on Assets (ttm)

15.6

Return on Equity (ttm)

26.1

Qtrly Rev. Growth

13.7

Gross Profit (p.s.)

7.989

Sales Per Share

12.552

EBITDA (p.s.)

5.763

Qtrly Earnings Growth

19.40

Operating Cash Flow (M)

123.26

Levered Free Cash Flow (M)

54.39

Statistics

Shares Out. (M)

Shares Float (M)

23.34

% Held by Insiders

23.78

% Held by Institutions

67.80

Shares Short (K)

1570

SharesShort PriorMonth (K)

1020

Valuation

P/E

29.61

P/E Growth Ratio

P/BV

6.18

P/S

9.10

P/CF

Dividend Yield

Stock Price History

52-Week High

137.38

52-Week Change (%)

52-Week Low

96.99

-3.1

* Strong Sell ** Sell *** Neutral **** Buy ***** Strong Buy

 

Symbol:

CBPO

Company Name:

China Biologic Products, Inc.

IPO Year:

n/a

Sector

Health Care

Industry:

Biotechnology: Biological Products (No Diagnostic Substances)

Headline News

Fri, 19 May 2017 20:05:00 +0000

China Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders

BEIJING, May 19, 2017 /PRNewswire/ -- China Biologic Products, Inc. ("China Biologic" or the "Company") (CBPO), a leading fully integrated plasma-based biopharmaceutical company in China, announced today that the Securities and Exchange Commission has declared effective a Form F-4 Registration Statement, which includes a Proxy Statement of China Biologic and also constitutes a Prospectus of China Biologic Products Holdings, Inc. (the "proxy statement/prospectus"), in connection with the proposed redomicile of China Biologic as a Cayman Islands company. The redomicile will be effected through a merger (the "Merger") of China Biologic with China Biologic Products Holdings, Inc., an exempted company incorporated under the laws of the Cayman Islands and a wholly owned subsidiary of China Biologic, resulting in the shares of China Biologic being converted into the right to receive shares of China Biologic Products Holdings, Inc.

Mon, 08 May 2017 13:27:15 +0000

Edited Transcript of CBPO earnings conference call or presentation 4-May-17 11:30am GMT

Q1 2017 China Biologic Products Inc Earnings Call

Fri, 05 May 2017 02:29:00 +0000

This Chinese Pharma Stock Has 20% Upside

Jefferies just upgraded its price target on the U.S.-listed pharma stock from USD128 to USD140 a share, suggesting another 20% upside. Analysts at Jefferies say that the market should react positively should China Biologic, which makes plasma-based pharma products like human albumin, win tenders in China’s Jiangsu and Shandong provinces. The upgrade came on the back of China Biologic reporting broadly in-line first quarter results.

Thu, 04 May 2017 11:05:00 +0000

Investor Network: China Biologic Products, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 4, 2017 / China Biologic Products, Inc. (NASDAQ: CBPO ) will be discussing their earnings results in their Q1 Earnings Call to be held May 4, 2017 at 7:30 AM Eastern Time. ...

Thu, 04 May 2017 09:02:37 +0000

China Biologic Products posts 1Q profit

On a per-share basis, the Beijing-based company said it had profit of $1.06. Earnings, adjusted for non-recurring costs, were $1.32 per share. The biopharmaceutical company posted revenue of $91.5 million ...

All China Stocks -All Information About China Stocks Traded In U.S. Stock Markets

All China Stocks dedicates to providing information about China stocks traded in U.S. stock markets, includes: markets headline news, Chinese stocks headline news, Chinese stocks to watch, Chinese stock real time quotes, Chinese stock company profiles and annual reports, objective Chinese stock research and analysis.

©2006 AllChinaStocks.com  Home  Stock Quotes  Stock Picks  Stock Symbols  Allindianstocks  Stoxline  Contact us